nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000756	0.000757	CcSEcCtD
Pamidronate—Shock—Lisinopril—systemic scleroderma	0.000754	0.000755	CcSEcCtD
Pamidronate—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000751	0.000752	CcSEcCtD
Pamidronate—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00075	0.000751	CcSEcCtD
Pamidronate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000748	0.00075	CcSEcCtD
Pamidronate—Neutropenia—Prednisone—systemic scleroderma	0.000748	0.000749	CcSEcCtD
Pamidronate—Tachycardia—Lisinopril—systemic scleroderma	0.000747	0.000749	CcSEcCtD
Pamidronate—Abdominal pain—Azathioprine—systemic scleroderma	0.000746	0.000747	CcSEcCtD
Pamidronate—Body temperature increased—Azathioprine—systemic scleroderma	0.000746	0.000747	CcSEcCtD
Pamidronate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000741	0.000743	CcSEcCtD
Pamidronate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00074	0.000741	CcSEcCtD
Pamidronate—Diarrhoea—Captopril—systemic scleroderma	0.00074	0.000741	CcSEcCtD
Pamidronate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000739	0.00074	CcSEcCtD
Pamidronate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000738	CcSEcCtD
Pamidronate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000736	0.000737	CcSEcCtD
Pamidronate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000734	0.000736	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000734	0.000735	CcSEcCtD
Pamidronate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000733	0.000734	CcSEcCtD
Pamidronate—Nausea—Mometasone—systemic scleroderma	0.000731	0.000732	CcSEcCtD
Pamidronate—Anorexia—Lisinopril—systemic scleroderma	0.00073	0.000731	CcSEcCtD
Pamidronate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000729	0.00073	CcSEcCtD
Pamidronate—Pain—Mycophenolic acid—systemic scleroderma	0.000727	0.000728	CcSEcCtD
Pamidronate—Constipation—Mycophenolic acid—systemic scleroderma	0.000727	0.000728	CcSEcCtD
Pamidronate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000723	0.000724	CcSEcCtD
Pamidronate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000717	0.000718	CcSEcCtD
Pamidronate—Hypotension—Lisinopril—systemic scleroderma	0.000716	0.000717	CcSEcCtD
Pamidronate—Dizziness—Captopril—systemic scleroderma	0.000715	0.000716	CcSEcCtD
Pamidronate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000714	0.000715	CcSEcCtD
Pamidronate—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000712	0.000713	CcSEcCtD
Pamidronate—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00071	0.000711	CcSEcCtD
Pamidronate—Body temperature increased—Leflunomide—systemic scleroderma	0.000705	0.000706	CcSEcCtD
Pamidronate—Abdominal pain—Leflunomide—systemic scleroderma	0.000705	0.000706	CcSEcCtD
Pamidronate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000701	0.000702	CcSEcCtD
Pamidronate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0007	0.000701	CcSEcCtD
Pamidronate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0007	0.000701	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000698	0.000699	CcSEcCtD
Pamidronate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000699	CcSEcCtD
Pamidronate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000695	0.000696	CcSEcCtD
Pamidronate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000695	0.000696	CcSEcCtD
Pamidronate—Insomnia—Lisinopril—systemic scleroderma	0.000693	0.000694	CcSEcCtD
Pamidronate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000692	0.000693	CcSEcCtD
Pamidronate—Paraesthesia—Lisinopril—systemic scleroderma	0.000688	0.000689	CcSEcCtD
Pamidronate—Vomiting—Captopril—systemic scleroderma	0.000688	0.000689	CcSEcCtD
Pamidronate—Dyspnoea—Lisinopril—systemic scleroderma	0.000683	0.000684	CcSEcCtD
Pamidronate—Rash—Captopril—systemic scleroderma	0.000682	0.000683	CcSEcCtD
Pamidronate—Dermatitis—Captopril—systemic scleroderma	0.000681	0.000682	CcSEcCtD
Pamidronate—Somnolence—Lisinopril—systemic scleroderma	0.000681	0.000682	CcSEcCtD
Pamidronate—Headache—Captopril—systemic scleroderma	0.000677	0.000678	CcSEcCtD
Pamidronate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000677	0.000678	CcSEcCtD
Pamidronate—Dyspepsia—Lisinopril—systemic scleroderma	0.000674	0.000675	CcSEcCtD
Pamidronate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000672	0.000673	CcSEcCtD
Pamidronate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000672	0.000673	CcSEcCtD
Pamidronate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000671	0.000672	CcSEcCtD
Pamidronate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000671	0.000672	CcSEcCtD
Pamidronate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000668	CcSEcCtD
Pamidronate—Decreased appetite—Lisinopril—systemic scleroderma	0.000666	0.000667	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000661	0.000662	CcSEcCtD
Pamidronate—Fatigue—Lisinopril—systemic scleroderma	0.00066	0.000661	CcSEcCtD
Pamidronate—Shock—Mycophenolate mofetil—systemic scleroderma	0.00066	0.000661	CcSEcCtD
Pamidronate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000658	0.000659	CcSEcCtD
Pamidronate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000657	0.000658	CcSEcCtD
Pamidronate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000657	0.000658	CcSEcCtD
Pamidronate—Constipation—Lisinopril—systemic scleroderma	0.000655	0.000656	CcSEcCtD
Pamidronate—Pain—Lisinopril—systemic scleroderma	0.000655	0.000656	CcSEcCtD
Pamidronate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000655	0.000656	CcSEcCtD
Pamidronate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000649	0.00065	CcSEcCtD
Pamidronate—Diarrhoea—Azathioprine—systemic scleroderma	0.000646	0.000647	CcSEcCtD
Pamidronate—Haemoglobin—Prednisone—systemic scleroderma	0.000643	0.000644	CcSEcCtD
Pamidronate—Nausea—Captopril—systemic scleroderma	0.000642	0.000643	CcSEcCtD
Pamidronate—Haemorrhage—Prednisone—systemic scleroderma	0.00064	0.000641	CcSEcCtD
Pamidronate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00064	0.000641	CcSEcCtD
Pamidronate—Asthenia—Leflunomide—systemic scleroderma	0.000639	0.00064	CcSEcCtD
Pamidronate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000631	0.000632	CcSEcCtD
Pamidronate—Pruritus—Leflunomide—systemic scleroderma	0.000631	0.000631	CcSEcCtD
Pamidronate—Connective tissue disorder—Prednisone—systemic scleroderma	0.000629	0.00063	CcSEcCtD
Pamidronate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000627	0.000628	CcSEcCtD
Pamidronate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000626	0.000627	CcSEcCtD
Pamidronate—Neutropenia—Methotrexate—systemic scleroderma	0.000625	0.000626	CcSEcCtD
Pamidronate—Dizziness—Azathioprine—systemic scleroderma	0.000624	0.000625	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000621	0.000622	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000611	0.000612	CcSEcCtD
Pamidronate—Asthenia—Mycophenolic acid—systemic scleroderma	0.00061	0.000611	CcSEcCtD
Pamidronate—Diarrhoea—Leflunomide—systemic scleroderma	0.00061	0.000611	CcSEcCtD
Pamidronate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000607	0.000608	CcSEcCtD
Pamidronate—Abdominal pain—Lisinopril—systemic scleroderma	0.000605	0.000606	CcSEcCtD
Pamidronate—Body temperature increased—Lisinopril—systemic scleroderma	0.000605	0.000606	CcSEcCtD
Pamidronate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Pamidronate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Pamidronate—Vomiting—Azathioprine—systemic scleroderma	0.0006	0.000601	CcSEcCtD
Pamidronate—Pneumonia—Methotrexate—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Pamidronate—Eye disorder—Prednisone—systemic scleroderma	0.000598	0.000599	CcSEcCtD
Pamidronate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000598	0.000599	CcSEcCtD
Pamidronate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Pamidronate—Infestation—Methotrexate—systemic scleroderma	0.000596	0.000597	CcSEcCtD
Pamidronate—Infestation NOS—Methotrexate—systemic scleroderma	0.000596	0.000597	CcSEcCtD
Pamidronate—Rash—Azathioprine—systemic scleroderma	0.000595	0.000596	CcSEcCtD
Pamidronate—Dermatitis—Azathioprine—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Pamidronate—Flushing—Prednisone—systemic scleroderma	0.000594	0.000595	CcSEcCtD
Pamidronate—Headache—Azathioprine—systemic scleroderma	0.000591	0.000592	CcSEcCtD
Pamidronate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000591	0.000592	CcSEcCtD
Pamidronate—Dizziness—Leflunomide—systemic scleroderma	0.000589	0.00059	CcSEcCtD
Pamidronate—Renal failure—Methotrexate—systemic scleroderma	0.000586	0.000587	CcSEcCtD
Pamidronate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000584	CcSEcCtD
Pamidronate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000582	0.000583	CcSEcCtD
Pamidronate—Stomatitis—Methotrexate—systemic scleroderma	0.000581	0.000582	CcSEcCtD
Pamidronate—Angiopathy—Prednisone—systemic scleroderma	0.000581	0.000582	CcSEcCtD
Pamidronate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000579	0.00058	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000579	0.00058	CcSEcCtD
Pamidronate—Immune system disorder—Prednisone—systemic scleroderma	0.000578	0.000579	CcSEcCtD
Pamidronate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000575	CcSEcCtD
Pamidronate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000575	CcSEcCtD
Pamidronate—Haematuria—Methotrexate—systemic scleroderma	0.000568	0.000569	CcSEcCtD
Pamidronate—Vomiting—Leflunomide—systemic scleroderma	0.000567	0.000568	CcSEcCtD
Pamidronate—Alopecia—Prednisone—systemic scleroderma	0.000566	0.000567	CcSEcCtD
Pamidronate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000564	0.000565	CcSEcCtD
Pamidronate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000562	0.000563	CcSEcCtD
Pamidronate—Rash—Leflunomide—systemic scleroderma	0.000562	0.000563	CcSEcCtD
Pamidronate—Dermatitis—Leflunomide—systemic scleroderma	0.000561	0.000562	CcSEcCtD
Pamidronate—Nausea—Azathioprine—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Pamidronate—Headache—Leflunomide—systemic scleroderma	0.000558	0.000559	CcSEcCtD
Pamidronate—Malnutrition—Prednisone—systemic scleroderma	0.000557	0.000558	CcSEcCtD
Pamidronate—Erythema—Prednisone—systemic scleroderma	0.000557	0.000558	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—systemic scleroderma	0.000556	0.000557	CcSEcCtD
Pamidronate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000553	0.000554	CcSEcCtD
Pamidronate—Asthenia—Lisinopril—systemic scleroderma	0.000549	0.00055	CcSEcCtD
Pamidronate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Pamidronate—Pruritus—Lisinopril—systemic scleroderma	0.000542	0.000543	CcSEcCtD
Pamidronate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—systemic scleroderma	0.000538	0.000539	CcSEcCtD
Pamidronate—Rash—Mycophenolic acid—systemic scleroderma	0.000536	0.000537	CcSEcCtD
Pamidronate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—systemic scleroderma	0.000535	0.000536	CcSEcCtD
Pamidronate—Headache—Mycophenolic acid—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Pamidronate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00053	0.000531	CcSEcCtD
Pamidronate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00053	0.000531	CcSEcCtD
Pamidronate—Nausea—Leflunomide—systemic scleroderma	0.000529	0.00053	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000528	0.000529	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Pamidronate—Diarrhoea—Lisinopril—systemic scleroderma	0.000524	0.000525	CcSEcCtD
Pamidronate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000517	0.000518	CcSEcCtD
Pamidronate—Anaemia—Prednisone—systemic scleroderma	0.000515	0.000516	CcSEcCtD
Pamidronate—Agitation—Prednisone—systemic scleroderma	0.000512	0.000513	CcSEcCtD
Pamidronate—Angioedema—Prednisone—systemic scleroderma	0.000509	0.00051	CcSEcCtD
Pamidronate—Dizziness—Lisinopril—systemic scleroderma	0.000506	0.000507	CcSEcCtD
Pamidronate—Nausea—Mycophenolic acid—systemic scleroderma	0.000505	0.000506	CcSEcCtD
Pamidronate—Malaise—Prednisone—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—systemic scleroderma	0.0005	0.000501	CcSEcCtD
Pamidronate—Syncope—Prednisone—systemic scleroderma	0.0005	0.000501	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Pamidronate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000494	0.000495	CcSEcCtD
Pamidronate—Loss of consciousness—Prednisone—systemic scleroderma	0.00049	0.000491	CcSEcCtD
Pamidronate—Vomiting—Lisinopril—systemic scleroderma	0.000487	0.000488	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—systemic scleroderma	0.000485	0.000486	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—systemic scleroderma	0.000483	0.000484	CcSEcCtD
Pamidronate—Rash—Lisinopril—systemic scleroderma	0.000483	0.000484	CcSEcCtD
Pamidronate—Convulsion—Prednisone—systemic scleroderma	0.000483	0.000484	CcSEcCtD
Pamidronate—Dermatitis—Lisinopril—systemic scleroderma	0.000482	0.000483	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000482	0.000483	CcSEcCtD
Pamidronate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000481	0.000482	CcSEcCtD
Pamidronate—Hypertension—Prednisone—systemic scleroderma	0.000481	0.000482	CcSEcCtD
Pamidronate—Chills—Methotrexate—systemic scleroderma	0.00048	0.000481	CcSEcCtD
Pamidronate—Headache—Lisinopril—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Pamidronate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Pamidronate—Arthralgia—Prednisone—systemic scleroderma	0.000474	0.000475	CcSEcCtD
Pamidronate—Myalgia—Prednisone—systemic scleroderma	0.000474	0.000475	CcSEcCtD
Pamidronate—Anxiety—Prednisone—systemic scleroderma	0.000473	0.000474	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Pamidronate—Discomfort—Prednisone—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Pamidronate—Erythema—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Pamidronate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000459	0.00046	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—systemic scleroderma	0.000456	0.000457	CcSEcCtD
Pamidronate—Nausea—Lisinopril—systemic scleroderma	0.000455	0.000456	CcSEcCtD
Pamidronate—Oedema—Prednisone—systemic scleroderma	0.000455	0.000456	CcSEcCtD
Pamidronate—Anaphylactic shock—Prednisone—systemic scleroderma	0.000455	0.000456	CcSEcCtD
Pamidronate—Infection—Prednisone—systemic scleroderma	0.000452	0.000453	CcSEcCtD
Pamidronate—Back pain—Methotrexate—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Pamidronate—Shock—Prednisone—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Pamidronate—Nervous system disorder—Prednisone—systemic scleroderma	0.000446	0.000447	CcSEcCtD
Pamidronate—Tachycardia—Prednisone—systemic scleroderma	0.000444	0.000445	CcSEcCtD
Pamidronate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Pamidronate—Hyperhidrosis—Prednisone—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Pamidronate—Anorexia—Prednisone—systemic scleroderma	0.000434	0.000434	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000432	0.000433	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Pamidronate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Pamidronate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000424	CcSEcCtD
Pamidronate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Pamidronate—Headache—Mycophenolate mofetil—systemic scleroderma	0.00042	0.000421	CcSEcCtD
Pamidronate—Malaise—Methotrexate—systemic scleroderma	0.00042	0.000421	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—systemic scleroderma	0.000417	0.000418	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000414	0.000415	CcSEcCtD
Pamidronate—Insomnia—Prednisone—systemic scleroderma	0.000411	0.000412	CcSEcCtD
Pamidronate—Paraesthesia—Prednisone—systemic scleroderma	0.000408	0.000409	CcSEcCtD
Pamidronate—Cough—Methotrexate—systemic scleroderma	0.000406	0.000407	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Pamidronate—Dyspepsia—Prednisone—systemic scleroderma	0.0004	0.000401	CcSEcCtD
Pamidronate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Pamidronate—Decreased appetite—Prednisone—systemic scleroderma	0.000395	0.000396	CcSEcCtD
Pamidronate—Fatigue—Prednisone—systemic scleroderma	0.000392	0.000393	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Pamidronate—Constipation—Prednisone—systemic scleroderma	0.000389	0.00039	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—systemic scleroderma	0.000383	0.000384	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00038	0.000381	CcSEcCtD
Pamidronate—Infection—Methotrexate—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Pamidronate—Feeling abnormal—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000372	0.000373	CcSEcCtD
Pamidronate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000367	0.000368	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—systemic scleroderma	0.000362	0.000363	CcSEcCtD
Pamidronate—Body temperature increased—Prednisone—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Pamidronate—Abdominal pain—Prednisone—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—systemic scleroderma	0.000355	0.000356	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000346	0.000347	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—systemic scleroderma	0.000341	0.000342	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Pamidronate—Hypersensitivity—Prednisone—systemic scleroderma	0.000335	0.000336	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—systemic scleroderma	0.00033	0.000331	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000328	0.000329	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Pamidronate—Asthenia—Prednisone—systemic scleroderma	0.000326	0.000327	CcSEcCtD
Pamidronate—Pain—Methotrexate—systemic scleroderma	0.000325	0.000326	CcSEcCtD
Pamidronate—Pruritus—Prednisone—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000313	0.000314	CcSEcCtD
Pamidronate—Diarrhoea—Prednisone—systemic scleroderma	0.000311	0.000312	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Pamidronate—Dizziness—Prednisone—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Pamidronate—Vomiting—Prednisone—systemic scleroderma	0.000289	0.00029	CcSEcCtD
Pamidronate—FDPS—connective tissue—systemic scleroderma	0.000289	0.207	CbGeAlD
Pamidronate—Rash—Prednisone—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Pamidronate—Dermatitis—Prednisone—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Pamidronate—Headache—Prednisone—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Pamidronate—Nausea—Prednisone—systemic scleroderma	0.00027	0.000271	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Pamidronate—FDPS—smooth muscle tissue—systemic scleroderma	0.000264	0.189	CbGeAlD
Pamidronate—FDPS—skin of body—systemic scleroderma	0.000261	0.187	CbGeAlD
Pamidronate—Diarrhoea—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—systemic scleroderma	0.000251	0.000252	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Pamidronate—Rash—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—systemic scleroderma	0.000239	0.00024	CcSEcCtD
Pamidronate—Headache—Methotrexate—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Pamidronate—Nausea—Methotrexate—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Pamidronate—FDPS—digestive system—systemic scleroderma	0.000209	0.149	CbGeAlD
Pamidronate—FDPS—tendon—systemic scleroderma	0.000199	0.142	CbGeAlD
Pamidronate—FDPS—lung—systemic scleroderma	0.000174	0.125	CbGeAlD
